| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.17 | 0.003 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.006 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |